Literature DB >> 23141758

Association of lipoprotein subfractions and coronary artery calcium in patient at intermediate cardiovascular risk.

Borut Jug1, Jenny Papazian, Robert Lee, Matthew J Budoff.   

Abstract

More precise estimation of the atherogenic lipid parameters could improve identification of residual risk beyond what is possible using traditional lipid risk factors. The aim of the present study was to explore the association between advanced analysis of lipoprotein subfractions and the prevalence of coronary artery calcium. Consecutive participants at intermediate cardiovascular risk who were undergoing computed tomographic assessment of coronary calcium (calcium score) were included. Using a validated ultracentrifugation method (the vertical autoprofile II test), cholesterol in eluting lipoprotein subfractions [i.e., low- (LDL), very-low-, intermediate-, and high-density lipoprotein subclasses, lipoprotein (a), and predominant LDL distribution] was directly quantified. A total of 410 patients were included (29% women, mean age 57 years), of whom 297 (72.4%) had coronary artery calcium. LDL pattern B (predominance of small dense particles) emerged as an independent predictor of coronary calcium after adjustment for traditional risk factors (odds ratio 4.46, 95% confidence interval 1.19 to 16.7). However, after additional stratification for dyslipidemia, as defined by conventional lipid profiling, a statistically significant prediction was only retained for high-density lipoprotein subfraction 2 (odds ratio 3.45, 95% confidence interval 2.03 to 50.1) and "real" LDL (odds ratio 6.10, 95% confidence interval 1.26 to 23.41) in the normolipidemia group and for lipoprotein (a) (odds ratio 7.81, 95% confidence interval 1.41 to 43.5) in the dyslipidemic group. In conclusion, advanced assessment of the lipoprotein subfractions [i.e., LDL pattern B, high-density lipoprotein subfraction 2, "real" LDL, and lipoprotein (a)] using the vertical autoprofile II test provided additional information to that of conventional risk factors on the prevalence of coronary artery calcium in patients at intermediate cardiovascular risk.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23141758      PMCID: PMC4277703          DOI: 10.1016/j.amjcard.2012.09.016

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  32 in total

Review 1.  Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology.

Authors:  Matthew J Budoff; Stephan Achenbach; Roger S Blumenthal; J Jeffrey Carr; Jonathan G Goldin; Philip Greenland; Alan D Guerci; Joao A C Lima; Daniel J Rader; Geoffrey D Rubin; Leslee J Shaw; Susan E Wiegers
Journal:  Circulation       Date:  2006-10-02       Impact factor: 29.690

Review 2.  Role of low-density lipoprotein apheresis.

Authors:  Paul Ziajka
Journal:  Am J Cardiol       Date:  2005-08-22       Impact factor: 2.778

3.  Quantification of HDL2 and HDL3 cholesterol by the Vertical Auto Profile-II (VAP-II) methodology.

Authors:  K R Kulkarni; S M Marcovina; R M Krauss; D W Garber; A M Glasscock; J P Segrest
Journal:  J Lipid Res       Date:  1997-11       Impact factor: 5.922

4.  Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

Authors:  B Lamarche; S Moorjani; B Cantin; G R Dagenais; P J Lupien; J P Després
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

5.  Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project.

Authors:  Allen J Taylor; Jody Bindeman; Irwin Feuerstein; Felix Cao; Michael Brazaitis; Patrick G O'Malley
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

6.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

7.  Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality.

Authors:  Khurram Nasir; Leslee J Shaw; Sandy T Liu; Steven R Weinstein; Tristen R Mosler; Phillip R Flores; Ferdinand R Flores; Paolo Raggi; Daniel S Berman; Roger S Blumenthal; Matthew J Budoff
Journal:  J Am Coll Cardiol       Date:  2007-08-20       Impact factor: 24.094

8.  Relationship between plasma lipid concentrations and HDL subclasses.

Authors:  Yuye Yang; Bingyu Yan; Mingde Fu; Yanhua Xu; Ying Tian
Journal:  Clin Chim Acta       Date:  2004-12-24       Impact factor: 3.786

9.  Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients.

Authors:  Matthew J Budoff; Leslee J Shaw; Sandy T Liu; Steven R Weinstein; Tristen P Mosler; Philip H Tseng; Ferdinand R Flores; Tracy Q Callister; Paolo Raggi; Daniel S Berman
Journal:  J Am Coll Cardiol       Date:  2007-04-20       Impact factor: 24.094

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  5 in total

Review 1.  Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

2.  Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study.

Authors:  Olufunmilayo H Obisesan; Minghao Kou; Frances M Wang; Ellen Boakye; Yasuyuki Honda; S M Iftekhar Uddin; Omar Dzaye; Albert D Osei; Olusola A Orimoloye; Candace M Howard-Claudio; Josef Coresh; Roger S Blumenthal; Ron C Hoogeveen; Matthew J Budoff; Kunihiro Matsushita; Christie M Ballantyne; Michael J Blaha
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

3.  A Randomized Double-blind Controlled Trial of Lactobacillus acidophilus Plus Bifidobacterium bifidum versus Placebo in Patients with Hypercholesterolemia.

Authors:  Sanguansak Rerksuppaphol; Lakkana Rerksuppaphol
Journal:  J Clin Diagn Res       Date:  2015-03-01

4.  The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis.

Authors:  Moshrik Abd Alamir; Michael Goyfman; Adib Chaus; Firas Dabbous; Leslie Tamura; Veit Sandfort; Alan Brown; Mathew Budoff
Journal:  J Lipids       Date:  2018-03-27

Review 5.  Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with 'Normal' LDL-C Levels.

Authors:  Harold Superko; Brenda Garrett
Journal:  Biomedicines       Date:  2022-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.